Indian Science Cruiser

Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Current Havoc of TB and its Alleviation by Green Pharmacy Discipline : Medical Biotechnology


Affiliations
1 Post-Graduate Department of Biotechnology, St. Xavier’s College (Autonomous), 30, Mother Teresa Sarani, Kolkata -700 016, West Bengal, India
2 Department of Microbiology, Lady Brabourne College, P-1/2, Suhrawardy Avenue, Kolkata-700 017, West Bengal, India
     

   Subscribe/Renew Journal


Tuberculosis (TB) remains one of the deadliest diseases of humans, with a present worldwide annual mortality rate of over a million. Global resurgence of TB, and the emergence of multi-drug resistant TB (MDR-TB) and extensively-drug resistant TB (XDR-TB) in India call for the development of new anti-tubercular drugs to combat them. Medicinal plants from the rich heritage of Indian flora, a lesser-explored area as anti-TB green pharmacy till date, offer a hope for the development of alternative medicines, necessitating their potencies to be meticulously scanned and evaluated. For the effective control of MDR-strains of Mycobacterium tuberculosis, a systematic screening of plants would be the first step in the development of a suitable phytodrug, which would also be economically viable in the medicinal plant trade. Use of such non-conventional anti-TB herbal medicines is expected to acquire brisk popularity, owing to the toxicity and overwhelming side-effects of anti-tubercular allopathic medicines. In the present review, a situation report on the on-going global efforts to discover and develop drugs from twelve selected medicinal plants have been discussed, which have ample potential as anti-TB agents, as identified from various sources in the corresponding literature reviewed.

Keywords

Tuberculosis, Multi-drug Resistant TB (MDR-TB), Extensively-drug Resistant Tb (XDR-TB), Anti-tubercular Drugs, Green Pharmacy, Alternative Medicines, Phytodrug, Medicinal Plant Trade, Anti-tb Herbal Medicines.
User
Subscription Login to verify subscription
Notifications
Font Size

  • World Health Organization (WHO). Global tuberculosis report 2016. 2016. http://apps.who.int/iris/bitstre am/10665/250441/1/9789241565394-eng.pdf?ua=1. Accessed 4 May, 2017.

  • Central TB Division, Directorate General of Health Sciences, Ministry of Health & Family Welfare, Govt. of India. TB India 2015 Revised National TB Control Programme Annual Status Report, New Delhi. 2015.http://www.tbcindia.nic.in/index1.php?lan g=1&level=1&sublinkid=4737&lid=3275. Accessed 10 May, 2017.

  • Global tuberculosis control: WHO report 2011. 2011. http://apps.who.int/iris/ bitstream/10665/44728/1/97892 41564380_ eng.pdf. Accessed 27 February, 2016.

  • World Health Organization (WHO). Global tuberculosis report 2013. 2013. http:// who.int/tb/publications/global_report/en/.Accessed 10 April, 2014.

  • Lawn SD, and Zumla AI. Tuberculosis. Lancet. 2011; 378(9785):57-72.

  • Wikipedia, (2017), “Standard of Living in India.” Web. http://en.wikipedia.org/wiki/ Standard_of_living_in_India. Accessed 4 May, 2017.

  • The Times of India Kolkata, (2003), “TB rates high in Bengal: WHO.” Web. http://timesofindia.indiatimes.com/city/ kolkata/TB-rates-high-in-Bengal-WHO/ articleshow/41308700.cms. Accessed 16 October, 2014.

  • N. N. Ibekwe, and S. J. Ameh, Plant natural product research on tuberculosis drug discovery and development: A situation report with focus on Nigerian biodiversity. Afr J Biotechnol. 2014; 13(23):2307-2320.

  • World Health Organization (WHO). Global tuberculosis report 2015. 2015. http://apps.who.int/iris/bitstream/10665/191102/1/9789 241565059_eng.pdf. Accessed 27 February, 2016.

  • A. Vikrant, A Review on Anti-Tubercular Plants. Int J PharmTech Res. 2011; 3(2):872880.

  • MI. Shareef Chapter 1. pdf - Shodhganga.http://shodhganga.inflibnet.ac.in/ bitstream/10603/37093 /5/chapter%201.pdf. 2015. Accessed 30 January, 2016.

  • TH Yu, CM. Wu Stability of allicin in garlic juice. J Food Sci. 1989; 54:977-981.

  • S. Ankri, and D. Mirelman, Antimicrobial properties of allicin from garlic. Microb Infect. 1999; 1:125–129.

  • S. Roy, and A. Nag Chaudhuri, Bactericidal Effect of Garlic Extract on Mycobacterium smegmatis. International Journal of Scientific Research. 2015; 4(3):1-6.

  • S. Roy, and A. Nag Chaudhuri, Changes in signal cross-talking in Mycobacterium smegmatis infected murine macrophages in presence of aqueous garlic extract. International Journal of Applied Research. 2016; 2(5):810-816.

  • D. G. Sheeba, K. S. Gomathi, and T. Citarasu, Anti-Mycobacterial and Phytochemical Investigation of Methanol Extracts of few Medicinal Plants. Journal of Chemical and Pharmaceutical Sciences. 2015; 8(3).

  • R. Kaur, and H. Kaur, Antitubercular Activity and Phytochemical Screening of Selected Medicinal Plants. Orient J Chem. 2015; 31(1):597-600.

  • S. Suhitha, S. K. Devi, K. Gunasekaran, H. C. Pakyntein, A. Bhattacharjee, and D.Velmurugan, Phytochemical Analyses and Activity of Herbal Medicinal Plants of NorthEast India for Anti-Diabetic, Anti-Cancer and Anti-Tuberculosis and their Docking Studies. Current Topics in Medicinal Chemistry. 2015; 15(1):21-23.


Abstract Views: 421

PDF Views: 3




  • Current Havoc of TB and its Alleviation by Green Pharmacy Discipline : Medical Biotechnology

Abstract Views: 421  |  PDF Views: 3

Authors

Souvik Roy
Post-Graduate Department of Biotechnology, St. Xavier’s College (Autonomous), 30, Mother Teresa Sarani, Kolkata -700 016, West Bengal, India
Aditi Nag Chaudhuri
Department of Microbiology, Lady Brabourne College, P-1/2, Suhrawardy Avenue, Kolkata-700 017, West Bengal, India

Abstract


Tuberculosis (TB) remains one of the deadliest diseases of humans, with a present worldwide annual mortality rate of over a million. Global resurgence of TB, and the emergence of multi-drug resistant TB (MDR-TB) and extensively-drug resistant TB (XDR-TB) in India call for the development of new anti-tubercular drugs to combat them. Medicinal plants from the rich heritage of Indian flora, a lesser-explored area as anti-TB green pharmacy till date, offer a hope for the development of alternative medicines, necessitating their potencies to be meticulously scanned and evaluated. For the effective control of MDR-strains of Mycobacterium tuberculosis, a systematic screening of plants would be the first step in the development of a suitable phytodrug, which would also be economically viable in the medicinal plant trade. Use of such non-conventional anti-TB herbal medicines is expected to acquire brisk popularity, owing to the toxicity and overwhelming side-effects of anti-tubercular allopathic medicines. In the present review, a situation report on the on-going global efforts to discover and develop drugs from twelve selected medicinal plants have been discussed, which have ample potential as anti-TB agents, as identified from various sources in the corresponding literature reviewed.

Keywords


Tuberculosis, Multi-drug Resistant TB (MDR-TB), Extensively-drug Resistant Tb (XDR-TB), Anti-tubercular Drugs, Green Pharmacy, Alternative Medicines, Phytodrug, Medicinal Plant Trade, Anti-tb Herbal Medicines.

References





DOI: https://doi.org/10.24906/isc%2F2017%2Fv31%2Fi3%2F155596